tiprankstipranks
Trending News
More News >
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market
Advertisement

Mineralys Therapeutics, Inc. (MLYS) Similar Stocks

Compare
586 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$39.99
$3.02B
236.05%
6 Buy
1 Hold
0 Sell
Strong Buy
Viking Therapeutics
$25.57
$2.88B
-58.51%
16 Buy
2 Hold
0 Sell
Strong Buy
Xenon
$37.98
$2.82B
-1.73%
12 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$22.37
$2.83B
-24.09%
10 Buy
7 Hold
0 Sell
Moderate Buy
NewAmsterdam Pharma Company
$28.50
$3.21B
75.60%
9 Buy
1 Hold
0 Sell
Strong Buy
Centessa Pharmaceuticals
$23.26
$3.11B
47.31%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLYS
Mineralys Therapeutics, Inc.
39.99
27.88
230.22%
VKTX
Viking Therapeutics
25.57
-37.74
-59.61%
XENE
Xenon
37.98
-1.39
-3.53%
APLS
Apellis Pharmaceuticals
22.37
-6.47
-22.43%
NAMS
NewAmsterdam Pharma Company
28.50
11.90
71.69%
CNTA
Centessa Pharmaceuticals
23.26
7.27
45.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis